Clinical Center of Vojvodina, Clinic of Hematology

Novi Sad 21 000

0 studies enrolling now · 4 studies all time

What they study most

Blood Cancer, Diffuse Large B Cell Lymphoma, Hematological Malignancy, Leukemia, Lymphocytic, Chronic, B-Cell, Multiple Myeloma, Non-Hodgkin's B-cell Lymphoma, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Relapsed Multiple Myeloma, Small Lymphocytic Leukemia

Studies at this site

• A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma — Completed
• Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL — Stopped early